IDH1 and myelodysplastic syndrome: Furthermore, a meta-analysis combining the current and six previously published studies on IDH1/2 mutations and MDS indicated IDH1/2 mutations negatively affected OS (HR, 1.62; 95% CI, 1.27–2.09) and LFS 2.21 (95% CI, 1.48–3.30).